Related Experiment Video
Updated: Jan 28, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Unusual Manifestation of Ulcerative Colitis.
Amna Basheer M Ahmed1, Badr M Rasheed Alsaleem1
1Pediatric Gastroenterology Division, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Chronic recurrent multifocal osteomyelitis (CRMO) and ulcerative colitis (UC) rarely co-occur. This case report highlights successful treatment of pediatric CRMO and UC with IBD therapy, suggesting a potential therapeutic link.
Area of Science:
- Pediatric rheumatology
- Gastroenterology
- Inflammatory disorders
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is an inflammatory bone disorder.
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC), can manifest with extraintestinal rheumatic symptoms.
- The association between CRMO and UC is infrequently documented.
Observation:
- A 10-year-old Saudi female presented with CRMO symptoms including fever and foot pain.
- Ulcerative colitis was diagnosed based on endoscopic and histological findings following a history of diarrhea and anemia.
- The patient experienced significant improvement with IBD-specific therapy.
Findings:
- This case represents the first reported instance of pediatric CRMO associated with UC in Saudi Arabia.
- The co-occurrence of CRMO and UC in this patient responded favorably to established IBD treatments.
- The findings suggest a potential therapeutic benefit of IBD therapy for CRMO.
Implications:
- This case underscores the importance of considering IBD in pediatric patients with CRMO.
- It supports the utilization of IBD therapies as a treatment modality for CRMO.
- Further research into the pathogenic links between CRMO and UC may elucidate novel treatment strategies.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Unusual Results
According to the range rule of thumb, any value above or below two standard deviations, 2σ from the mean, μ is considered unusual.
Maximum unusual value =...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
z Scores and Unusual Values
This score indicates how far a value is from the mean in terms of standard deviation. For example, if a data value has a z score of +1, the researcher can infer that the particular data value is one standard deviation above the mean. If another data...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.